HOWARU® Protect Baby
The distinctive strain within HOWARU® Protect Baby is well-documented, proven safe and backed by robust clinical trials – including one of the largest clinical trials of infants to date.
Altogether, the combination of L. plantarum ATCC- 202195 plus the prebiotic FOS has been shown to provide significant immune and digestive health benefits in infants, after just seven days of supplementation.
Download the handout to learn more.
- HOWARU® Lactiplantibacillus plantarum LP-202195™
- Fructooligosaccharide (FOS)
1B CFU | HOWARU® Lactiplantibacillus plantarum Lp202195 + 150 mg Fructooligosaccharide (FOS)
Early Life DevelopmentAdvantages of HOWARU® Protect Baby
- Provides immune support for infants
- Supports baby’s gut and immune system development
- Promotes increased levels of healthy
ESTABLISHING A HEALTHY MICROBIOTA AND IMMUNE SUPPORT IN EARLY LIFE
L. plantarum ATCC-202195*, the strain in HOWARU® Protect Baby, and fructo-oligosaccharide (FOS) were investigated for their effects to prevent severe infections in neonatal infants in a randomized, double-blind, placebo-controlled clinical trial with 4,556 healthy newborns.Infants received oral supplementation of 1B CFU of L. plantarum – and 150 mg of FOS – daily for seven days, starting on the second to fourth day of life; participants were monitored daily for over 60 days.Researchers found that the synbiotic supplementation was associated with statistically significant reduced risk of sepsis by 42% (p<0.001), lower respiratory tract infection by 34% (p=0.002) and diarrhea by 80% (p<0.001).
References: 1. Panigrahi et al,. 2008; Panigrahi, P., et al,. 2017; Chandel DS et al., 2017.
